Peptic Ulcer Drugs Market, By Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonists, Antibiotics, Ulcer Protective), By Disease Indication (Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Re

Peptic Ulcer Drugs Market, By Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonists, Antibiotics, Ulcer Protective), By Disease Indication (Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)), By Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Peptic ulcers are also classed as stomach ulcers or gastric ulcers can cause abdominal pain and discomfort in the abdomen. There are two types of peptic ulcer found gastric ulcer and duodenal ulcer. Gastric ulcers are commonly found in the inner lining of the stomach whereas the duodenal ulcers are formed in small intestines. Peptic ulcers are caused due to reduction of mucus layer that protects the stomach from digestive juices. Major symptoms of peptic ulcers constitute of burping, nausea, vomiting, loss in appetite, and etc. The treatment of peptic ulcers depend on the type of ulcer and the treatment regime mostly comprises of proton pump inhibitors, and antibiotics.
Key features of the study:
This report provides in-depth analysis of the Peptic Ulcer Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Peptic Ulcer Drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Abbott Laboratories, AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC, Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Peptic Ulcer Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Peptic Ulcer Drugs market
Detailed Segmentation:
Peripheral Intravenous Catheter Market, By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonists
Antibiotics
Ulcer Protective
Peripheral Intravenous Catheter Market, By Disease Indication:
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
Peripheral Intravenous Catheter Market, By Distribution Channel:
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Peripheral Intravenous Catheter Market, By Region:
North America
By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonists
Antibiotics
Ulcer Protective
By Disease Indication
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
By Distribution Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
By Country:
U.S.
Canada
Latin America
By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonists
Antibiotics
Ulcer Protective
By Disease Indication
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
By Distribution Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonists
Antibiotics
Ulcer Protective
By Disease Indication
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
By Distribution Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonists
Antibiotics
Ulcer Protective
By Disease Indication
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
By Distribution Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonists
Antibiotics
Ulcer Protective
By Disease Indication
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
By Distribution Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Proton Pump Inhibitors
Potassium-Competitive Acid Blocker (P-CAB)
Antacids
H2- Antagonists
Antibiotics
Ulcer Protective
By Disease Indication
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
By Distribution Channel
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Daewoong Pharmaceutical Co., Ltd. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Takeda Pharmaceutical Co., Ltd.
Pfizer Inc.
AstraZeneca plc.
RedHill Biopharma
Cadila Healthcare Ltd.
Novitium Pharma LLC.
Boehringer Ingelheim GmbH
Eisai Co. Ltd.
Yuhan Corporation
GlaxoSmithKline plc.
“*” marked represents similar segmentation in other categories in the respective section.